Interposed Nucleus aDBS for Ataxia

Recruiting N/A Interventional Study
Spinocerebellar Ataxia (SCA) Spinocerebellar Ataxia Type 6
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
21 – 89
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
5 (estimated)
Sponsor
University of Florida · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This is a single-center, open-label study designed to evaluate the feasibility, safety, and preliminary efficacy of cerebellar adaptive deep brain stimulation (aDBS) in adults with spinocerebellar ataxia type 6 (SCA6). A total of 5 participants will be enrolled. Participants will undergo surgical implantation of deep brain stimulation (DBS) leads targeting the motor interposed nucleus of the cere…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * A diagnosis of SCA6 by a movement disorders specialist following established criteria recommended by the Movement Disorders Society * A positive genetic test for SCA6 * A total score ≥ 8 on the Scale of the Assessment and Rating of Ataxia (SARA) rating scale * Ability to walk …
Contacts

Julia C Gonzalez, BA

(352) 265-0111

Julia.Gonzalez@neurology.ufl.edu

CONTACT

Emily Rafferty, PhD

Emily.Rafferty@neurology.ufl.edu

CONTACT